Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN - AcademicCME

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN

0.5

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs) credit

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

course Faculty

No data was found

Related Courses

From PCP to Nephrologist & Supportive Patient Education to Achieve Continuity of Care ...

Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiolog...

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Pati...